Get the Stockscreener App
1.14
0.88%
0.01
After Hours:
1.13
-0.01
-0.88%
Opko Health Inc stock is traded at $1.14, with a volume of 1.16M.
It is up +0.88% in the last 24 hours and down -8.06% over the past month.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
See More
Previous Close:
$1.13
Open:
$1.12
24h Volume:
1.16M
Relative Volume:
0.39
Market Cap:
$865.34M
Revenue:
$606.88M
Net Income/Loss:
$-225.68M
P/E Ratio:
-3.7723
EPS:
-0.3022
Net Cash Flow:
$-190.82M
1W Performance:
-2.56%
1M Performance:
-8.06%
6M Performance:
-25.97%
1Y Performance:
-30.91%
1-Day Range:
$1.11
$1.15
1-Week Range:
$1.095
$1.18
52-Week Range:
$1.095
$1.64
Opko Health Inc Stock (OPK) Company Profile
Name
Opko Health Inc
Sector
Industry
Phone
305-575-4181
Address
4400 BISCAYNE BLVD., MIAMI, FL
Compare OPK vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OPK
Opko Health Inc
|
1.14 | 865.34M | 606.88M | -225.68M | -190.82M | -0.3022 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Opko Health Inc Stock (OPK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-20-25 | Initiated | JP Morgan | Neutral |
| Oct-31-25 | Downgrade | Jefferies | Buy → Hold |
| Apr-25-25 | Initiated | JP Morgan | Neutral |
| Jun-29-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Dec-15-22 | Initiated | H.C. Wainwright | Buy |
| Jan-24-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Jun-21-21 | Initiated | Ladenburg Thalmann | Buy |
| Nov-25-19 | Initiated | Piper Jaffray | Overweight |
| Mar-02-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-14-17 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-21-16 | Reiterated | Standpoint Research | Buy |
| Jun-03-16 | Initiated | Standpoint Research | Buy |
| Mar-31-16 | Reiterated | Barrington Research | Outperform |
| Oct-16-15 | Initiated | JP Morgan | Overweight |
| Sep-11-15 | Downgrade | Jefferies | Buy → Hold |
| Mar-03-15 | Downgrade | Oppenheimer | Outperform → Perform |
| May-12-14 | Reiterated | Oppenheimer | Outperform |
| Mar-14-14 | Initiated | Oppenheimer | Outperform |
| Nov-13-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-30-13 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-22-12 | Initiated | Barrington Research | Outperform |
| Dec-01-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jul-14-11 | Initiated | Ladenburg Thalmann | Buy |
View All
Opko Health Inc Stock (OPK) Latest News
Profit Review: Is OPKO Health Inc stock trending bullishExit Point & Daily Oversold Bounce Ideas - baoquankhu1.vn
Stock List: Research Stocks from Around the World - gurufocus.com
Aug EndMonth: What are the future prospects of OPKO Health Inc2026 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Here's why you should hold OPK stock in your portfolio for now - MSN
OPKO Health (NASDAQ:OPK) Sets New 12-Month LowHere's What Happened - MarketBeat
OPKO Health Inc Stock: Business Model, Growth Drivers, and Key Investor Considerations in Diagnostic - AD HOC NEWS
Entera Bio (NASDAQ: ENTX) 2025 loss widens as oral peptide pipeline advances - Stock Titan
An oral bone-building tablet for osteoporosis moves toward Phase 3 - Stock Titan
How The OPKO Health (OPK) Story Is Shifting With Mixed Analyst Signals - Yahoo Finance
OPK (OPKO Health) Shiller PE Ratio : (As of Mar. 26, 2026) - GuruFocus
OPKO Health: The Waiting Game Continues (NASDAQ:OPK) - Seeking Alpha
Movement Recap: Whats the beta of OPKO Health Inc stock2026 PostEarnings & High Win Rate Trade Tips - baoquankhu1.vn
Aug Gainers: What is the PEG ratio of OPKO Health Inc2026 Technicals & Long-Term Growth Stock Strategies - baoquankhu1.vn
ETF Watch: Is OPKO Health Inc stock trending bullish2026 Fed Impact & Verified Technical Trade Signals - baoquankhu1.vn
FOMO Trade: Will OPKO Health Inc benefit from seasonality2026 Price Action Summary & Trade Opportunity Analysis - baoquankhu1.vn
OPKO Health Inc stock faces pressure amid insider buying and Labcorp deal aftermath - AD HOC NEWS
OPKO Health Inc stock faces analyst cuts as earnings outlook darkens amid biotech pressures - AD HOC NEWS
Zacks Research Lowers Earnings Estimates for OPKO Health - MarketBeat
Opko Health Inc. (OPK) builds value through partnerships and innovation - MSN
OPK Technical Analysis & Stock Price Forecast - Intellectia AI
Opko, Prologis, Williams, APA, Paysafe: Insider Moves Exposed - TipRanks
Tranche Update on OPKO Health, Inc.'s Equity Buyback Plan announced on July 18, 2024. - marketscreener.com
Barrington lowers PT on OPKO Health (OPK), keeps a buy - msn.com
Opko Health director Paganelli buys $11,350 in company stock By Investing.com - Investing.com India
OPKO Health (NASDAQ:OPK) Director Buys $11,400.00 in Stock - MarketBeat
Barrington Lowers PT on OPKO Health (OPK), Keeps a Buy - Insider Monkey
Opko Health director Paganelli buys $11,350 in company stock - Investing.com
Opko Health (OPK) director adds 10,000 shares in open-market buy - Stock Titan
OPKO Health (NASDAQ: OPK) director granted 50,000 options at $1.17 - Stock Titan
OPKO Health (NASDAQ: OPK) director reports initial common stock holdings - Stock Titan
Zacks Research Forecasts OPKO Health FY2028 Earnings - MarketBeat
Portfolio Update: What is the dividend yield of OPKO Health Inc2026 Performance Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
OPKO Health Appoints Subbarao V. Uppaluri, Ph.D. as New Director – SEC 8-K Filing March 2026 - Minichart
OPK SEC FilingsOpko Health 10-K, 10-Q, 8-K Forms - Stock Titan
OPKO Health appoints Subbarao V. Uppaluri to board of directors By Investing.com - Investing.com South Africa
OPKO Health appoints Subbarao V. Uppaluri to board of directors - Investing.com
Opko Health Adds Independent Director to Strengthen Governance - TipRanks
OPKO appoints Subbarao V. Uppaluri to Board following Richard Krasno's passing - TradingView
OPKO Health (OPK) appoints former CFO Subbarao Uppaluri to board - Stock Titan
Here's Why You Should Hold OPK Stock in Your Portfolio for Now - TradingView
OPKO Health (OPK) reports Q4 loss, tops revenue estimates - MSN
Aug Ideas: Is OPKO Health Inc stock forming a cup and handleQuarterly Profit Review & Daily Momentum Trading Reports - baoquankhu1.vn
Market Moves: Is OPKO Health Inc forming bullish engulfing patternsSwing Trade & Community Trade Idea Sharing Platform - baoquankhu1.vn
OPK Earning Date, Earning Analysis and Earning Prediction - intellectia.ai
Trading Recap: Is OPKO Health Inc likely to announce a buyback2026 Pullback Review & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Aug Final Week: Is OPKO Health Inc a strong growth stock2026 Momentum & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Support Test: What is the Moat Score of OPKO Health Inc2026 Chart Watch & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Quarterly Earnings: Will OPKO Health Inc benefit from seasonalityMarket Activity Report & Risk Controlled Daily Plans - baoquankhu1.vn
OPKO Health (NASDAQ:OPK) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
Opko Health Inc Stock (OPK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):